相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Apalutamide, Darolutamide and Enzalutamide for Nonmetastatic Castration-Resistant Prostate Cancer (nmCRPC): A Critical Review
Carlo Cattrini et al.
CANCERS (2022)
Inhibiting Translation Elongation with SVC112 Suppresses Cancer Stem Cells and Inhibits Growth in Head and Neck Squamous Carcinoma
Stephen B. Keysar et al.
CANCER RESEARCH (2020)
Novel Therapeutic Strategies for CDK4/6 Inhibitors in Metastatic Castrate-Resistant Prostate Cancer
Adam M. Kase et al.
ONCOTARGETS AND THERAPY (2020)
Second-Generation Antiandrogens: From Discovery to Standard of Care in Castration Resistant Prostate Cancer
Meghan A. Rice et al.
FRONTIERS IN ONCOLOGY (2019)
Mechanisms and Approaches for Overcoming enzalutamide Resistance in Prostate Cancer
Alexandra Vander Ark et al.
FRONTIERS IN ONCOLOGY (2018)
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer
Neel Shah et al.
ELIFE (2017)
SOCS3 Modulates the Response to Enzalutamide and Is Regulated by Androgen Receptor Signaling and CpG Methylation in Prostate Cancer Cells
Florian Handle et al.
MOLECULAR CANCER RESEARCH (2016)
A Review of the Botany, Phytochemistry, Pharmacology and Toxicology of Rubiae Radix et Rhizoma
Mingqiu Shan et al.
MOLECULES (2016)
Intracrine Androgens and AKR1C3 Activation Confer Resistance to Enzalutamide in Prostate Cancer
Chengfei Liu et al.
CANCER RESEARCH (2015)
The Cistrome and Gene Signature of Androgen Receptor Splice Variants in Castration Resistant Prostate Cancer Cells
Ji Lu et al.
JOURNAL OF UROLOGY (2015)
The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis
Mark M. Pomerantz et al.
NATURE GENETICS (2015)
Bouvardin is a Radiation Modulator with a Novel Mechanism of Action
Stefanie A. Stickel et al.
RADIATION RESEARCH (2015)
ACSL4 promotes prostate cancer growth, invasion and hormonal resistance
Xinyu Wu et al.
ONCOTARGET (2015)
Androgen receptor: structure, role in prostate cancer and drug discovery
M. H. Eileen Tan et al.
ACTA PHARMACOLOGICA SINICA (2015)
Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer
Irfan A. Asangani et al.
NATURE (2014)
Evolution of androgen receptor targeted therapy for advanced prostate cancer
Yien Ning Sophia Wong et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
Emmanuel S. Antonarakis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Bromodomain Protein BRD4 Is Required for Estrogen Receptor-Dependent Enhancer Activation and Gene Transcription
Sankari Nagarajan et al.
CELL REPORTS (2014)
Androgen Receptor Splice Variants in the Era of Enzalutamide and Abiraterone
Mary Nakazawa et al.
HORMONES & CANCER (2014)
Maintaining and reprogramming genomic androgen receptor activity in prostate cancer
Ian G. Mills
NATURE REVIEWS CANCER (2014)
Androgen Receptor Splice Variants Mediate Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cell Lines
Yingming Li et al.
CANCER RESEARCH (2013)
Glucocorticoid Receptor Confers Resistance to Antiandrogens by Bypassing Androgen Receptor Blockade
Vivek K. Arora et al.
CELL (2013)
Molecular mechanisms underlying RB protein function
Frederick A. Dick et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
Control of cell cycle transcription during G1 and S phases
Cosetta Bertoli et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
Post-translational modification of the androgen receptor
Daniel Gioeli et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
Per-N-methylated analogues of an antitumor bicyclic hexapeptide RA-VII
Yukio Hitotsuyanagi et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Antitumor Cyclic Hexapeptides from Rubia Plants: History, Chemistry, and Mechanism (2005-2011)
Si Meng Zhao et al.
CHIMIA (2011)
Increased androgen receptor transcription: a cause of castration-resistant prostate cancer and a possible therapeutic target
Masaki Shiota et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2011)
Design and synthesis of a bis(cycloisodityrosine) analogue of RA-VII, an antitumor bicyclic hexapeptide
Ji-Ean Lee et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
New cytotoxic bicyclic hexapeptides, RA-XXIII and RA-XXIV, from Rubia cordifolia L.
Ji-Ean Lee et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2008)
Eukaryotic protein synthesis inhibitors identified by comparison of cytotoxicity profiles
J Chan et al.
RNA (2004)
分享论文
